We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600958:SSEOrient Securities Company Limited Class A Analysis

Data as of 2026-03-14 - not real-time

CN¥9.76

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Orient Securities is trading at CNY 9.76, comfortably below its 20‑day SMA of 10.03, 50‑day SMA of 10.42 and 200‑day SMA of 10.58, indicating a short‑term bearish bias. Technical indicators reinforce this view: the RSI sits at 33, hinting at oversold conditions, while the MACD histogram remains negative and the volume trend is decreasing, suggesting limited buying pressure. Fundamentally, the stock appears markedly undervalued – the DCF‑derived fair value of 38.03 is nearly four times the current price, and the PE of 16.5 is only marginally above the industry average of 16.35. The company boasts a solid dividend yield of 2.25% with a modest payout ratio (~30%), strong cash reserves exceeding total debt, and a respectable operating margin of 44%, though a high debt‑to‑equity ratio of 241 signals leverage concerns.
Given the low beta of 0.22, modest 30‑day volatility of 13.4%, and a supportive balance sheet, the downside risk is limited, but regulatory and sector‑specific headwinds in China’s capital markets temper optimism. The convergence of a deep valuation gap, sustainable dividend, and near‑term technical support at 9.66 suggests potential upside if market sentiment stabilizes.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above the support level of 9.66
  • Oversold RSI indicating potential short‑term bounce
  • Decreasing volume limiting immediate upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value far exceeds current market price
  • Sustainable dividend yield of 2.25% with low payout ratio
  • Strong cash position offsetting high leverage

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term valuation gap suggests significant upside
  • Stable earnings margins and consistent dividend policy
  • Resilient business model within China's capital markets

Key Metrics & Analysis

Financial Health

Revenue Growth40.00%
Profit Margin22.96%
P/E Ratio16.5
ROE6.32%
ROA1.23%
Debt/Equity241.35
P/B Ratio1.0
Op. Cash FlowCN¥11.4B
Industry P/E16.4

Technical Analysis

TrendBearish
RSI33.3
SupportCN¥9.66
ResistanceCN¥10.47
MA 20CN¥10.03
MA 50CN¥10.42
MA 200CN¥10.58
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueCN¥38.03
GradeUndervalued
TypeValue
Dividend Yield2.25%

Risk Assessment

Beta0.22
Volatility13.42%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.